The effect of TDCS of on schizophrenia.
Conditions
Interventions
Intervention 1: Intervention group is transcranial stimulated by 2 milliamps ,for 20 minutes within ten sessions for maximum 5 days. Intervention 2: Control group is transcranial stimulated by sham (
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Having a diagnosis of psychiatric illness in Razi Hospital, Tabriz No disability Family consent to participate in the program Having a diagnosis of Schizophrenia (diagnosis of schizophrenia is based on the DSM5 diagnostic criteria and SCID-based psychiatric interview and clinical examination)
Exclusion criteria
Exclusion criteria: Age under 18 and over 45 years History of severe sensory-motor disorders Vision problems Hearing problems Severe intelligence and cognitive impairments Epilepsy and seizures History of brain mass Substance dependence History of intracranial implants (such as prostheses, shunts, stimulators, electrodes) The presence of any metal object that is close to the head (for example, inside the mouth) and can not be separated Having a cardiac pacemaker History of recent strokes and MI History of degenerative brain disorders such as Alzheimer's and Parkinson's diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of total and Phosphorylated Tau Protein in Patients with Schizophrenia. Timepoint: 2cc of fasting blood sample for each patient is taken once before starting and once after all sessions of TDCS. Method of measurement: By ELISA kits and in the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Chalabianloo
Tabriz University of Medical Sciences
Outcome results
None listed